How Medicines Law & Policy is Aiding the Covid-19 Response
The Covid-19 pandemic has laid bare concerns about access to medicines and vaccines to address the pandemic. Unprecedented research efforts are under way to develop new tools. In particular, Covid-19 vaccines that are essential to save lives and end the pandemic. The question of how to ensure that these products will be universally available is becoming pressing. ML&P experts have been helping to respond to this question with explanations of policy options for governments and support for key global initiatives that will encourage and facilitate the sharing of intellectual property related to Covid-19 technologies. See below for ML&P insight (in the form of blogs or briefs), useful tools for governments seeking to use flexibilities in the World Trade Organization’s Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement to increase access to medical technology for Covid-19, and important initiatives ML&P is supporting. ML&P is also updating its TRIPS Flexibilities Database to include Covid-19 related instances.